3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism

被引:171
作者
Huang, CK
Wei, P
Fan, KQ
Liu, Y
Lai, LH [1 ]
机构
[1] Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China
[2] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China
关键词
D O I
10.1021/bi036022q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SARS 3C-like proteinase has been proposed to be a key enzyme for drug design against SARS. Lack of a suitable assay has been a major hindrance for enzyme kinetic studies and a large-scale inhibitor screen for SARS 3CL proteinase. Since SARS 3CL proteinase belongs to the cysteine protease family (family C3 in clan CB) with a chymotrypsin fold, it is important to understand the catalytic mechanism of SARS 3CL proteinase to determine whether the proteolysis proceeds through a general base catalysis mechanism like chymotrypsin or an ion pair mechanism like papain. We have established a continuous colorimetric assay for SARS 3CL proteinase and applied it to study the enzyme catalytic mechanism. The proposed catalytic residues His41 and Cys145 were confirmed to be critical for catalysis by mutating to Ala, while the Cys145 to Set mutation resulted in an active enzyme with a 40-fold lower activity. From the pH dependency of catalytic activity, the pK(a)'s for His41 and Cys145 in the wild-type enzyme were estimated to be 6.38 and 8.34, while the pK(a)'s for His41 and Ser145 in the C145S mutant were estimated to be 6.15 and 9.09, respectively. The C145S mutant has a normal isotope effect in D2O for general base catalysis, that is, reacts slower in D2O, while the wild-type enzyme shows an inverse isotope effect which may come from the lower activation enthalpy. The pK(a) values measured for the active site residues and the activity of the C145S mutant are consistent with a general base catalysis mechanism and cannot be explained by a thiolate-imidazolium ion pair model.
引用
收藏
页码:4568 / 4574
页数:7
相关论文
共 33 条
  • [1] Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
    Anand, K
    Ziebuhr, J
    Wadhwani, P
    Mesters, JR
    Hilgenfeld, R
    [J]. SCIENCE, 2003, 300 (5626) : 1763 - 1767
  • [2] Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain
    Anand, K
    Palm, GJ
    Mesters, JR
    Siddell, SG
    Ziebuhr, J
    Hilgenfeld, R
    [J]. EMBO JOURNAL, 2002, 21 (13) : 3213 - 3224
  • [3] MECHANISM OF ACTION OF CYSTEINE PROTEINASES - OXYANION BINDING-SITE IS NOT ESSENTIAL IN THE HYDROLYSIS OF SPECIFIC SUBSTRATES
    ASBOTH, B
    STOKUM, E
    KHAN, IU
    POLGAR, L
    [J]. BIOCHEMISTRY, 1985, 24 (03) : 606 - 609
  • [4] The refined crystal structure of the 3C gene product from hepatitis A virus: Specific proteinase activity and RNA recognition
    Bergmann, EM
    Mosimann, SC
    Chernaia, MM
    Malcolm, BA
    James, MNG
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (03) : 2436 - 2448
  • [5] THE INTERPLAY OF ELECTROSTATIC AND BINDING INTERACTIONS DETERMINING ACTIVE-CENTER CHEMISTRY AND CATALYTIC ACTIVITY IN ACTINIDIN AND PAPAIN
    BROCKLEHURST, K
    ODRISCOLL, M
    KOWLESSUR, D
    PHILLIPS, IR
    TEMPLETON, W
    THOMAS, EW
    TOPHAM, CM
    WHARTON, CW
    [J]. BIOCHEMICAL JOURNAL, 1989, 257 (01) : 309 - 310
  • [6] Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS
    Chou, KC
    Wei, DQ
    Zhong, WZ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (01) : 148 - 151
  • [7] Sortase from Staphylococcus aureus does not contain a thiolate-imidazolium ion pair in its active site
    Connolly, KM
    Smith, BT
    Pilpa, R
    Ilangovan, U
    Jung, ME
    Clubb, RT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) : 34061 - 34065
  • [8] Electrostatic properties in the catalytic site of papain: A possible regulatory mechanism for the reactivity of the ion pair
    Dardenne, LE
    Werneck, AS
    Neto, MD
    Bisch, PM
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2003, 52 (02) : 236 - 253
  • [9] Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: Structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics
    Dragovich, PS
    Prins, TJ
    Zhou, R
    Johnson, TO
    Brown, EL
    Maldonado, FC
    Fuhrman, SA
    Zalman, LS
    Patick, AK
    Matthews, DA
    Hou, XJ
    Meador, JW
    Ferre, RA
    Worland, ST
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (05) : 733 - 738
  • [10] Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics
    Dragovich, PS
    Prins, TJ
    Zhou, R
    Brown, EL
    Maldonado, FC
    Fuhrman, SA
    Zalman, LS
    Tuntland, T
    Lee, CA
    Patick, AK
    Matthews, DA
    Hendrickson, TF
    Kosa, MB
    Liu, B
    Batugo, MR
    Gleeson, JPR
    Sakata, SK
    Chen, LJ
    Guzman, MC
    Meador, JW
    Ferre, RA
    Worland, ST
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (08) : 1607 - 1623